Skip Navigation

TA118 Colorectal cancer (metastatic) - bevacizumab & cetuximab: understanding NICE guidance

TA118 Colorectal cancer (metastatic) - bevacizumab & cetuximab: understanding NICE guidance

TA118 Colorectal cancer (metastatic) - bevacizumab & cetuximab: understanding NICE guidance
24 January 2007
(94.11 Kb 27 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

Order NICE guidance

Order printed copies of our guidance

Navigation